Developer docs
API playgroundTry for free, no card

Search company profiles

Virgo

Full company profile

uuid0004dms

Namestring
Virgo
Legal namestring
Virgo Surgical Video Solutions, Inc.
Websiteurl
virgosvs.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Virgo Surgical Video Solutions, Inc. is a Carlsbad, California-based private company founded in 2017 that builds AI infrastructure for gastrointestinal endoscopy. Its core product is EndoDINO, a proprietary self-supervised Vision Transformer (ViT-g/14) foundation model pre-trained on 130,037 endoscopy videos and 3.5 billion frames — described in the company's arXiv paper as the largest GI endoscopy dataset in the literature and 57x larger than the next largest public dataset. On top of EndoDINO, Virgo offers EndoML (an AI development environment launched at DDW 2025), Virgo Cloud (HIPAA-compliant cloud video capture and management paired with proprietary hardware devices that connect to endoscopy towers), and Virgo Trials (a clinical trial acceleration platform with capabilities including placebo response prediction, subgroup identification, Bayesian priors generation, and continuous AI scoring for UC/CD endoscopic healing).

The company sells through direct enterprise sales to academic medical centers, community hospitals, and private GI practices in the United States, with stated international expansion plans. Pricing is a tiered annual SaaS subscription based on physician users or data usage, supplemented by hardware sales and platform licensing. By 2025, Virgo's platform had recorded more than 3 million procedures across 148 US medical centers, capturing over 1 million new procedures annually. Secondary customer segments include pharmaceutical companies running IBD, ulcerative colitis, and Crohn's disease clinical trials (where Virgo's AI targets patient recruitment difficulty of 0.10-0.13 patients/month/site, placebo response variance, and objective endpoint scoring), and academic/AI researchers using EndoDINO embeddings and EndoML tooling.

Virgo has raised approximately $13.2M across disclosed rounds: a $1.5M seed (April 2018, led by Tom Williams), an $8M Series A (January 2022, led by FCA Venture Partners with Olympus Innovation Ventures participating), and a ~$3.7M round (July 2024, led by Waterline Ventures with UMass Memorial Health Care). Strategic partners and investors include Olympus (equipment), Alimentiv (GI-focused CRO), Satisfai Health (exclusive AI partnership), CTNx (clinical trial network), Bon Secours Health System, and the Rajpurkar Lab at Stanford. The company was co-founded by Matt Schwartz (CEO, previously at Intuitive Surgical), David Guaraglia (CTO), and Ian Strug (CCO), and has 11-50 employees.

Short descriptiontext

Virgo builds AI infrastructure for gastrointestinal endoscopy, combining a proprietary EndoDINO foundation model with HIPAA-compliant cloud video capture hardware and software. It sells to US academic medical centers, GI practices, and pharmaceutical companies running IBD and colorectal clinical trials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
endoscopy video capture, medical AI platform, clinical trial analytics, foundation model healthcare, GI endoscopy software
Industry3 codes
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code2 codes
  • Computer Systems Design Services541512
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Services-Prepackaged Software7372
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging AI / Endoscopy AI Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Subscription - Tiered Model
TypeSubscription Recurring
Description

Cloud-based video platform sold via subscription with tiered pricing based on number of physician users or data usage. Recurring revenue model with annual subscription terms.

virgosvs.com
2Virgo Hardware
TypeHardware Sales
Description

Smart hardware video recording devices (Virgo Hardware) that record video information relating to endoscopic medical procedures. Hardware sales as component of overall offering.

virgosvs.com
3AI/ML Platform Access
TypeSubscription Recurring
Description

Access to EndoML platform and EndoDINO foundation model for pharmaceutical research and AI development, likely sold as platform licensing or subscription.

virgosvs.com:443
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain
Pricing details1 tier
1Tiered subscription model based on physician users or data usage
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing based on number of physician users or data usage volume. Exact tiers and price points not publicly disclosed.

virgosvs.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1EndoDINO
Description

Virgo's foundation model for endoscopy — a state-of-the-art AI model trained on the largest GI endoscopy dataset (3.5 billion frames), used for scoring, prediction, detection, and biomarker discovery.

virgosvs.com:443
+3 more records
Core offering1 text field

Virgo provides an end-to-end endoscopy AI platform consisting of video capture hardware for endoscopic procedures, a HIPAA-compliant cloud infrastructure for storing and processing procedure data, and proprietary AI foundation models (EndoDINO, EndoML) trained on the largest proprietary endoscopy video dataset. The platform enables clinical trial acceleration, live AI applications such as polyp detection, and data-driven insights for gastroenterology practices, pharmaceutical sponsors, and academic researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • State-of-the-art 0.748 AUROC on HyperKvasir 3-class Mayo Endoscopic Scoring (frozen features)
+4 more records
Product overview1 text field

Virgo builds a unified platform centered on its EndoDINO foundation model for AI-powered endoscopy. The product portfolio consists of four integrated offerings: EndoDINO (the core Vision Transformer foundation model trained on 3.5 billion frames), EndoML (the development environment for building on EndoDINO), Virgo Cloud (video capture/management hardware and cloud platform), and Virgo Trials (clinical trial acceleration). The Virgo System combines smart hardware devices with a HIPAA-compliant cloud platform to capture, store, and analyze endoscopy video data at population scale.

Product and service1 record
1Virgo System (Endoscopy Video Capture Hardware)
Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Rajpurkar Lab
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-29
Description

Research collaboration to develop next-gen AI foundation model for endoscopy. The Rajpurkar Lab at Stanford is led by Dr. Pranav Rajpurkar, a leading researcher in medical AI. Combined expertise to advance endoscopy AI foundation models.

virgosvs.com:443
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-17
Description

Partnership to advance GI care across Bon Secours health system. Aims to enhance endoscopic procedure quality using Virgo's video and AI platform across multiple hospital sites.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-06
Description

Strategic partnership to expand and accelerate GI clinical trials. CTNx provides network of clinical trial sites for gastroenterology research. Virgo provides AI-powered video capture and analysis capabilities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-10-06
Description

Partnership to use AI-driven technology to enhance clinical trials in IBD and other GI diseases. Alimentiv is a CRO specializing in gastroenterology clinical research. Joint go-to-market for pharma clinical trial applications.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-07
Description

Exclusive partnership to bring AI to life in gastroenterology. Enables advanced AI-fueled video capture, decision support, and clinical research tools for endoscopists worldwide. Combines Virgo's video platform with Satisfai's AI capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Iterative Health builds AI for gastroenterology, including computer vision for colonoscopy polyp detection and inflammatory bowel disease assessment. Directly comparable to Virgo as a GI-focused AI startup serving endoscopists with similar foundation-model-adjacent capabilities and academic medical center GTM.

TypeBroad incumbent
Description

Medtronic's GI Genius is an FDA-cleared AI-assisted polyp detection system for colonoscopy — the first broadly deployed AI module in endoscopy. Direct competitive overlap on the AI-for-endoscopy axis, with the resources and distribution of a major medtech incumbent.

TypeDirect peer
Description

Satisfai Health is a strategic partner and peer in GI AI, focused on real-time decision support and clinical research tools for endoscopists. The companies have an exclusive partnership to bring AI to GI, with overlapping product surfaces in video analysis and clinical decision support.

TypeDirect peer
Description

Odin Vision (acquired by Olympus in 2022) develops AI for endoscopy, including polyp detection and characterization. Direct competitor building GI AI applications with deep OEM backing from Virgo's strategic investor.

TypeBroad incumbent
Description

Olympus is the world's leading endoscopy equipment manufacturer and Virgo's strategic investor via Olympus Innovation Ventures. Represents both a major channel partner and a potential competitive threat as it expands its own AI capabilities (including via Odin Vision).

TypeDirect peer
Description

Wision AI develops computer-aided detection (CADe) and computer-aided diagnosis (CADx) algorithms for GI endoscopy, particularly colonoscopy. A direct peer building AI vision models for clinical decision support in GI procedures.

TypeDirect peer
Description

AnX Robotica develops AI-augmented capsule endoscopy (NaviiCam) and other GI endoscopy systems with embedded computer vision. Direct peer in GI endoscopy AI, with a focus on small-bowel and capsule-based procedures.

TypeDirect peer
Description

MAGENTIQ-EYE develops AI-driven polyp detection and endoscopy analytics software, with regulatory clearances in Europe. Direct peer in GI endoscopy computer vision, comparable in product scope and target customer base.

TypeBroad incumbent
Description

Fujifilm is a top-three endoscopy equipment OEM with active AI initiatives and a CAD EYE polyp detection system. Broad incumbent whose installed-base strategy and in-house AI development represent a competitive threat to Virgo's third-party AI layer.

TypeRegional player
Description

Cosmo Pharmaceuticals has developed GI Genius AI in partnership with Medtronic and is building endoscopy AI applications primarily in European markets. A regional peer in GI AI with comparable technology scope, though with different geographic and commercial focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers16 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Virgo

Medical Imaging AI / Endoscopy AI Platformvirgosvs.com

Virgo builds AI infrastructure for gastrointestinal endoscopy, combining a proprietary EndoDINO foundation model with HIPAA-compliant cloud video capture hardware and software. It sells to US academic medical centers, GI practices, and pharmaceutical companies running IBD and colorectal clinical trials.

What Virgo does

Virgo Surgical Video Solutions, Inc. is a Carlsbad, California-based private company founded in 2017 that builds AI infrastructure for gastrointestinal endoscopy. Its core product is EndoDINO, a proprietary self-supervised Vision Transformer (ViT-g/14) foundation model pre-trained on 130,037 endoscopy videos and 3.5 billion frames — described in the company's arXiv paper as the largest GI endoscopy dataset in the literature and 57x larger than the next largest public dataset. On top of EndoDINO, Virgo offers EndoML (an AI development environment launched at DDW 2025), Virgo Cloud (HIPAA-compliant cloud video capture and management paired with proprietary hardware devices that connect to endoscopy towers), and Virgo Trials (a clinical trial acceleration platform with capabilities including placebo response prediction, subgroup identification, Bayesian priors generation, and continuous AI scoring for UC/CD endoscopic healing).

The company sells through direct enterprise sales to academic medical centers, community hospitals, and private GI practices in the United States, with stated international expansion plans. Pricing is a tiered annual SaaS subscription based on physician users or data usage, supplemented by hardware sales and platform licensing. By 2025, Virgo's platform had recorded more than 3 million procedures across 148 US medical centers, capturing over 1 million new procedures annually. Secondary customer segments include pharmaceutical companies running IBD, ulcerative colitis, and Crohn's disease clinical trials (where Virgo's AI targets patient recruitment difficulty of 0.10-0.13 patients/month/site, placebo response variance, and objective endpoint scoring), and academic/AI researchers using EndoDINO embeddings and EndoML tooling.

Virgo has raised approximately $13.2M across disclosed rounds: a $1.5M seed (April 2018, led by Tom Williams), an $8M Series A (January 2022, led by FCA Venture Partners with Olympus Innovation Ventures participating), and a ~$3.7M round (July 2024, led by Waterline Ventures with UMass Memorial Health Care). Strategic partners and investors include Olympus (equipment), Alimentiv (GI-focused CRO), Satisfai Health (exclusive AI partnership), CTNx (clinical trial network), Bon Secours Health System, and the Rajpurkar Lab at Stanford. The company was co-founded by Matt Schwartz (CEO, previously at Intuitive Surgical), David Guaraglia (CTO), and Ian Strug (CCO), and has 11-50 employees.

Virgo firmographics

Firmographics
Name
Virgo
Legal name
Virgo Surgical Video Solutions, Inc.
Website
https://virgosvs.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Virgo builds AI infrastructure for gastrointestinal endoscopy, combining a proprietary EndoDINO foundation model with HIPAA-compliant cloud video capture hardware and software. It sells to US academic medical centers, GI practices, and pharmaceutical companies running IBD and colorectal clinical trials.
Ownership category
akta.pro rank

Virgo industry classification

Industry
Product category
Medical Imaging AI / Endoscopy AI Platform
NAICS
Computer Systems Design Services (541512), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLAHADAB
Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Endoscopy video capture
  • Medical AI platform
  • Clinical trial analytics
  • Foundation model healthcare
  • GI endoscopy software

Where Virgo is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Virgo business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

  1. SaaS Subscription - Tiered Model: Cloud-based video platform sold via subscription with tiered pricing based on number of physician users or data usage. Recurring revenue model with annual subscription terms.
  2. Virgo Hardware: Smart hardware video recording devices (Virgo Hardware) that record video information relating to endoscopic medical procedures. Hardware sales as component of overall offering.
  3. AI/ML Platform Access: Access to EndoML platform and EndoDINO foundation model for pharmaceutical research and AI development, likely sold as platform licensing or subscription.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualTiered subscription model based on physician users or data usage

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Virgo product offering

Product offering

Core offering

Virgo provides an end-to-end endoscopy AI platform consisting of video capture hardware for endoscopic procedures, a HIPAA-compliant cloud infrastructure for storing and processing procedure data, and proprietary AI foundation models (EndoDINO, EndoML) trained on the largest proprietary endoscopy video dataset. The platform enables clinical trial acceleration, live AI applications such as polyp detection, and data-driven insights for gastroenterology practices, pharmaceutical sponsors, and academic researchers.

Product overview

Virgo builds a unified platform centered on its EndoDINO foundation model for AI-powered endoscopy. The product portfolio consists of four integrated offerings: EndoDINO (the core Vision Transformer foundation model trained on 3.5 billion frames), EndoML (the development environment for building on EndoDINO), Virgo Cloud (video capture/management hardware and cloud platform), and Virgo Trials (clinical trial acceleration). The Virgo System combines smart hardware devices with a HIPAA-compliant cloud platform to capture, store, and analyze endoscopy video data at population scale.

Differentiator

Problem solved

Functional benefit

Brands

  • EndoDINO: Virgo's foundation model for endoscopy — a state-of-the-art AI model trained on the largest GI endoscopy dataset (3.5 billion frames), used for scoring, prediction, detection, and biomarker discovery.
  • EndoML
  • Virgo Cloud
  • Virgo Trials

Products and services

  • Virgo System (Endoscopy Video Capture Hardware)

Quantifiable outcome

  • State-of-the-art 0.748 AUROC on HyperKvasir 3-class Mayo Endoscopic Scoring (frozen features)
  • +4 more outcomes

Companies that use Virgo

Customer profile

Named customers16 records

Segments3 records

Ideal customer profiles3 records

Virgo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Virgo partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • Rajpurkar LabcoreStrategic or Co-development Partner · 29 April 2026Research collaboration to develop next-gen AI foundation model for endoscopy. The Rajpurkar Lab at Stanford is led by Dr. Pranav Rajpurkar, a leading researcher in medical AI. Combined expertise to advance endoscopy AI foundation models.
  • Bon Secours Health SystemcoreStrategic or Co-development Partner · 17 August 2023Partnership to advance GI care across Bon Secours health system. Aims to enhance endoscopic procedure quality using Virgo's video and AI platform across multiple hospital sites.
  • The Clinical Trials Network (CTNx)coreStrategic or Co-development Partner · 6 April 2023Strategic partnership to expand and accelerate GI clinical trials. CTNx provides network of clinical trial sites for gastroenterology research. Virgo provides AI-powered video capture and analysis capabilities.
  • AlimentivcoreStrategic or Co-development Partner · 6 October 2022Partnership to use AI-driven technology to enhance clinical trials in IBD and other GI diseases. Alimentiv is a CRO specializing in gastroenterology clinical research. Joint go-to-market for pharma clinical trial applications.
  • Satisfai HealthcoreStrategic or Co-development Partner · 7 August 2022Exclusive partnership to bring AI to life in gastroenterology. Enables advanced AI-fueled video capture, decision support, and clinical research tools for endoscopists worldwide. Combines Virgo's video platform with Satisfai's AI capabilities.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Virgo competitors and assessment

Company assessment

Direct peers

  • Iterative Health: Iterative Health builds AI for gastroenterology, including computer vision for colonoscopy polyp detection and inflammatory bowel disease assessment. Directly comparable to Virgo as a GI-focused AI startup serving endoscopists with similar foundation-model-adjacent capabilities and academic medical center GTM.
  • Satisfai Health: Satisfai Health is a strategic partner and peer in GI AI, focused on real-time decision support and clinical research tools for endoscopists. The companies have an exclusive partnership to bring AI to GI, with overlapping product surfaces in video analysis and clinical decision support.
  • Odin Vision: Odin Vision (acquired by Olympus in 2022) develops AI for endoscopy, including polyp detection and characterization. Direct competitor building GI AI applications with deep OEM backing from Virgo's strategic investor.
  • Wision AI: Wision AI develops computer-aided detection (CADe) and computer-aided diagnosis (CADx) algorithms for GI endoscopy, particularly colonoscopy. A direct peer building AI vision models for clinical decision support in GI procedures.
  • AnX Robotica: AnX Robotica develops AI-augmented capsule endoscopy (NaviiCam) and other GI endoscopy systems with embedded computer vision. Direct peer in GI endoscopy AI, with a focus on small-bowel and capsule-based procedures.
  • MAGENTIQ-EYE: MAGENTIQ-EYE develops AI-driven polyp detection and endoscopy analytics software, with regulatory clearances in Europe. Direct peer in GI endoscopy computer vision, comparable in product scope and target customer base.

Broad incumbents

  • Medtronic (GI Genius): Medtronic's GI Genius is an FDA-cleared AI-assisted polyp detection system for colonoscopy — the first broadly deployed AI module in endoscopy. Direct competitive overlap on the AI-for-endoscopy axis, with the resources and distribution of a major medtech incumbent.
  • Olympus Corporation: Olympus is the world's leading endoscopy equipment manufacturer and Virgo's strategic investor via Olympus Innovation Ventures. Represents both a major channel partner and a potential competitive threat as it expands its own AI capabilities (including via Odin Vision).
  • Fujifilm Healthcare: Fujifilm is a top-three endoscopy equipment OEM with active AI initiatives and a CAD EYE polyp detection system. Broad incumbent whose installed-base strategy and in-house AI development represent a competitive threat to Virgo's third-party AI layer.

Regional players

  • Cosmo Pharmaceuticals (AI4GI): Cosmo Pharmaceuticals has developed GI Genius AI in partnership with Medtronic and is building endoscopy AI applications primarily in European markets. A regional peer in GI AI with comparable technology scope, though with different geographic and commercial focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Virgo social profiles

Digital presence

Virgo compliance and trust

Trust signal

Compliance2 records

Virgo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Virgo leadership team

Management profile

Number of profiles

Profiles3 records

Virgo funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Virgo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virgo

What does Virgo do?

Virgo provides an end-to-end endoscopy AI platform consisting of video capture hardware for endoscopic procedures, a HIPAA-compliant cloud infrastructure for storing and processing procedure data, and proprietary AI foundation models (EndoDINO, EndoML) trained on the largest proprietary endoscopy video dataset. The platform enables clinical trial acceleration, live AI applications such as polyp detection, and data-driven insights for gastroenterology practices, pharmaceutical sponsors, and academic researchers.

Is Virgo a public or private company?

Virgo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Virgo founded?

Virgo was founded in 2017. It employs 11 to 50 people.

Where is Virgo based?

Virgo is headquartered in San Francisco, United States, in the North America region.

How does Virgo make money?

Three revenue lines are on record. SaaS Subscription - Tiered Model is the primary driver. The others are virgo Hardware and AI/ML Platform Access.

Who are Virgo's main competitors?

Direct peers on record are Iterative Health, Satisfai Health, Odin Vision, Wision AI, AnX Robotica and MAGENTIQ-EYE. Broad incumbents are Medtronic (GI Genius), Olympus Corporation and Fujifilm Healthcare. Cosmo Pharmaceuticals (AI4GI) is listed as a regional player.

Does Virgo have an API?

No public API is recorded for Virgo.

What industry is Virgo in?

Virgo's product category is Medical Imaging AI / Endoscopy AI Platform. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HLAHADAB, Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation). Its NAICS code is 541512 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NeowinA stunning first black hole's “kick” heard through space and timeResearchers at the Instituto Galego de Física de Altas Enerxías (IGFAE) at the University of Santiago de Compostela have reported the first combined measurement of both the speed and direction of a black hole recoil following a merger, using data from the GW190412 event detected by Advanced LIGO and Virgo in 2019. The team found that higher-order modes in gravitational waves can reveal the previously inaccessible azimuthal angle, allowing them to calculate a recoil speed exceeding 50 km/s with approximately 95% confidence. The finding that the final black hole could escape dense star clusters provides new insight into how black holes grow and interact within galaxies.Business Wire BlogVirgo Launches U.S. Expansion, Bringing Institutional OTC Liquidity to 34 States in Collaboration With BalanceVirgo is expanding into the U.S. through Balance USA, bringing institutional OTC liquidity to 34 states. The collaboration enables pre-funded, atomic settlement and principal execution, with Balance USA handling regulated activities. Virgo's CEO Adam Cai said the U.S. is the most important institutional market for digital assets.EIN PresswireVirgo Announces Research Collaboration with The Rajpurkar Lab to Develop Next-Gen AI Foundation Model for EndoscopyVirgo announced a research collaboration with the Rajpurkar Lab at Harvard Medical School to develop a next-generation AI foundation model for GI endoscopy. Virgo will contribute over one million de-identified endoscopy videos from its proprietary dataset. The model aims to advance video-level understanding for disease detection, risk scoring, and treatment recommendation.OlympusamericaOlympus Innovation Ventures Backs Endoscopy Video and AI Company, Virgo Surgical Video SolutionsOlympus Innovation Ventures completed its first investment by participating in the Series A financing of Virgo Surgical Video Solutions, an AI-powered endoscopy video company based in Carlsbad, California. This strategic partnership aims to leverage Virgo's artificial intelligence and machine learning technologies to assist physicians in clinical workflows and improve patient care outcomes. The investment marks Olympus' entry into supporting emerging digital health startups focused on minimally invasive detection and treatment.VirgosvsEndoscopic Video & AnalysisThe article presents Virgo, a healthcare technology company that utilizes its AI foundation model EndoDINO to capture and analyze endoscopy procedure videos. The platform integrates with existing electronic health records and video feeds to automatically record procedures without altering clinical workflows. It highlights the model's training on over 130,000 procedures and claims benefits such as improved care quality and accelerated clinical trials.VirgosvsVirgo launches EndoML, a state-of-the-art AI development platform for gastroenterologists and pharmaceutical researchers, at DDW 2025Virgo Surgical Video Solutions, Inc. launched EndoML, an AI development platform for gastroenterologists and pharmaceutical researchers, at Digestive Disease Week 2025 in San Diego. The platform utilizes the company's EndoDINO foundation model, trained on over 130,000 GI endoscopy videos, to accelerate AI concept-to-clinic translation. EndoML integrates with VirgoTrials and allows users to train custom models using proprietary datasets with high accuracy.PR NewswireVirgo Launches EndoML: A Revolutionary AI Platform Powered by the EndoDINO Foundation ModelVirgo launched EndoML, a full-stack AI platform using its EndoDINO foundation model, built on Meta's DINOv2. The model is trained on over 1.75 million endoscopy videos and enables healthcare providers to train bespoke AI models for GI care. Early access partners include Beth Israel Deaconess Medical Center and Mount Sinai Health System.VirgosvsHow AI is Transforming GI ResearchArtificial intelligence is transforming gastrointestinal research by enhancing diagnostic precision, accelerating drug discovery, and enabling personalized treatment approaches for conditions like colorectal cancer and inflammatory bowel disease. Virgo Platform is actively developing state-of-the-art AI foundation models to accelerate downstream applications for GI endoscopy and precision medicine.GastroAmerican Gastroenterological Association invests in AI-fueled endoscopy capture and clinical trials platform, Virgo Surgical Video SolutionsThe American Gastroenterological Association announced on December 1, 2022 that its new venture capital fund, GI Opportunity Fund 1, completed its first investment in Carlsbad-based Virgo Surgical Video Solutions, closing Virgo's Series A. Virgo provides AI-enabled endoscopic procedure recording and patient recruitment tools, having captured over 400,000 procedures. The investment amount was not disclosed.PR NewswireAlimentiv, Satisfai Health et Virgo annoncent un partenariat visant à utiliser une technologie basée sur l'IA pour améliorer les essais cliniques dans les MII et autres maladies gastro-intestinalesAlimentiv, Satisfai Health, and Virgo have announced a strategic partnership to integrate AI-based imaging technology into clinical trials for inflammatory bowel disease (IBD) and other gastrointestinal conditions. The collaboration grants Alimentiv exclusive access to Satisfai's SmartScore central reading tool and Virgo's cloud-based video capture fleet to enhance trial efficiency and develop new assessment metrics. This initiative aims to accelerate the market entry of new therapies by improving the scalability and effectiveness of gastroenterology clinical studies.